These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The synergistic effect of sex hormone-binding globulin and aromatase genes on polycystic ovary syndrome phenotype. Xita N; Georgiou I; Lazaros L; Psofaki V; Kolios G; Tsatsoulis A Eur J Endocrinol; 2008 Jun; 158(6):861-5. PubMed ID: 18505907 [TBL] [Abstract][Full Text] [Related]
3. The role of sex hormone-binding globulin and androgen receptor gene variants in the development of polycystic ovary syndrome. Xita N; Georgiou I; Lazaros L; Psofaki V; Kolios G; Tsatsoulis A Hum Reprod; 2008 Mar; 23(3):693-8. PubMed ID: 18192296 [TBL] [Abstract][Full Text] [Related]
4. Androgen receptor gene CAG repeat polymorphism in women with polycystic ovary syndrome. Kim JJ; Choung SH; Choi YM; Yoon SH; Kim SH; Moon SY Fertil Steril; 2008 Dec; 90(6):2318-23. PubMed ID: 18191848 [TBL] [Abstract][Full Text] [Related]
5. CYP19 gene variants affect the assisted reproduction outcome of women with polycystic ovary syndrome. Lazaros L; Xita N; Hatzi E; Takenaka A; Kaponis A; Makrydimas G; Sofikitis N; Stefos T; Zikopoulos K; Georgiou I Gynecol Endocrinol; 2013 May; 29(5):478-82. PubMed ID: 23461365 [TBL] [Abstract][Full Text] [Related]
6. Association of genetic variants of insulin degrading enzyme with metabolic features in women with polycystic ovary syndrome. Wang K; You L; Shi Y; Wang L; Zhang M; Chen ZJ Fertil Steril; 2008 Aug; 90(2):378-84. PubMed ID: 17953957 [TBL] [Abstract][Full Text] [Related]
7. The (TAAAA)n microsatellite polymorphism in the SHBG gene influences serum SHBG levels in women with polycystic ovary syndrome. Ferk P; Teran N; Gersak K Hum Reprod; 2007 Apr; 22(4):1031-6. PubMed ID: 17189294 [TBL] [Abstract][Full Text] [Related]
8. CYP19 gene expression in subcutaneous adipose tissue is associated with blood pressure in women with polycystic ovary syndrome. Lecke SB; Morsch DM; Spritzer PM Steroids; 2011 Nov; 76(12):1383-8. PubMed ID: 21807013 [TBL] [Abstract][Full Text] [Related]
9. Clinical and metabolic characteristics of polycystic ovary syndrome without polycystic ovary: a pilot study on Chinese women. Shi Y; Gao X; Sun X; Zhang P; Chen Z Fertil Steril; 2008 Oct; 90(4):1139-43. PubMed ID: 17889857 [TBL] [Abstract][Full Text] [Related]
10. Estrogen receptor beta gene +1730 G/A polymorphism in women with polycystic ovary syndrome. Kim JJ; Choi YM; Choung SH; Yoon SH; Lee GH; Moon SY Fertil Steril; 2010 Apr; 93(6):1942-7. PubMed ID: 19185861 [TBL] [Abstract][Full Text] [Related]
11. No evidence of mutations in the P450 aromatase gene in patients with polycystic ovary syndrome. Söderlund D; Canto P; Carranza-Lira S; Méndez JP Hum Reprod; 2005 Apr; 20(4):965-9. PubMed ID: 15695318 [TBL] [Abstract][Full Text] [Related]
12. Polymorphisms in the CYP19 and AR genes--relation to bone mass and longitudinal bone changes in postmenopausal women with or without hormone replacement therapy: The Danish Osteoporosis Prevention Study. Tofteng CL; Kindmark A; Brändström H; Abrahamsen B; Petersen S; Stiger F; Stilgren LS; Jensen JE; Vestergaard P; Langdahl BL; Mosekilde L; Calcif Tissue Int; 2004 Jan; 74(1):25-34. PubMed ID: 14517714 [TBL] [Abstract][Full Text] [Related]
13. Association between CAPN10 UCSNP-43 gene polymorphism and polycystic ovary syndrome in Chilean women. Márquez JL; Pacheco A; Valdés P; Salazar LA Clin Chim Acta; 2008 Dec; 398(1-2):5-9. PubMed ID: 18722363 [TBL] [Abstract][Full Text] [Related]
14. Genetic determinants of insulin action in polycystic ovary syndrome. Haap M; Machicao F; Stefan N; Thamer C; Tschritter O; Schnuck F; Wallwiener D; Stumvoll M; Häring HU; Fritsche A Exp Clin Endocrinol Diabetes; 2005 May; 113(5):275-81. PubMed ID: 15926113 [TBL] [Abstract][Full Text] [Related]
15. Genetic polymorphisms of the glucocorticoid receptor may affect the phenotype of women with anovulatory polycystic ovary syndrome. Valkenburg O; Uitterlinden AG; Themmen AP; de Jong FH; Hofman A; Fauser BC; Laven JS Hum Reprod; 2011 Oct; 26(10):2902-11. PubMed ID: 21803757 [TBL] [Abstract][Full Text] [Related]
16. CYP19 (TTTA)n polymorphism and breast cancer risk in Brazilian women. Ribeiro FS; de Amorim LM; de Almeida Simão T; Mendonça GA; de Moura Gallo CV; Pinto LF Toxicol Lett; 2006 Jun; 164(1):90-5. PubMed ID: 16406421 [TBL] [Abstract][Full Text] [Related]
17. A common interleukin-6 gene promoter polymorphism influences the clinical characteristics of women with polycystic ovary syndrome. Walch K; Grimm C; Zeillinger R; Huber JC; Nagele F; Hefler LA Fertil Steril; 2004 Jun; 81(6):1638-41. PubMed ID: 15193488 [TBL] [Abstract][Full Text] [Related]
18. Pro12Ala polymorphism of the peroxisome proliferator-activated receptor-gamma gene in first-degree relatives of subjects with polycystic ovary syndrome. Yilmaz M; Ergün MA; Karakoç A; Yurtçu E; Yetkin I; Ayvaz G; Cakir N; Arslan M Gynecol Endocrinol; 2005 Oct; 21(4):206-10. PubMed ID: 16316841 [TBL] [Abstract][Full Text] [Related]
19. The association between genetic polymorphisms in CYP19 and breast cancer risk in Korean women. Kim JY; Lee CS; Kim HO; Jo YH; Lee J; Jung MH; Baik HH; Choe W; Kang I; Yoon KS Oncol Rep; 2009 Sep; 22(3):487-92. PubMed ID: 19639193 [TBL] [Abstract][Full Text] [Related]
20. Plasma adiponectin and insulin resistance in women with polycystic ovary syndrome. Ardawi MS; Rouzi AA Fertil Steril; 2005 Jun; 83(6):1708-16. PubMed ID: 15950640 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]